Article Versions Notes

Summers RJ, Jain J, Vasileiadi E, Smith B, Chimenti ML, Yeung TY, Kelvin J, Wang X, Frye SV, Earp HS, et al. Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia. Cancers. 2022; 14(24):6142. https://doi.org/10.3390/cancers14246142

Summers, Ryan J., Juhi Jain, Eleana Vasileiadi, Brittany Smith, Madison L. Chimenti, Tsz Y. Yeung, James Kelvin, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, and et al. 2022. "Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia" Cancers 14, no. 24: 6142. https://doi.org/10.3390/cancers14246142

Summers, R. J., Jain, J., Vasileiadi, E., Smith, B., Chimenti, M. L., Yeung, T. Y., Kelvin, J., Wang, X., Frye, S. V., Earp, H. S., Tyner, J. W., Dreaden, E. C., DeRyckere, D., & Graham, D. K. (2022). Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia. Cancers, 14(24), 6142. https://doi.org/10.3390/cancers14246142